APA (7th ed.) Citation

T, K., E, A., R, E., AS, D., D, Ö. Y., V, Y., . . . R, T. (2024). Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study. European neurology, 87(4), 203. https://doi.org/10.1159/000539376

Chicago Style (17th ed.) Citation

T, Kızılay, Akbayir E, Erol R, Demir AS, Özkan Yaşargün D, Yilmaz V, Tuzun E, and Turkoglu R. "Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study." European Neurology 87, no. 4 (2024): 203. https://doi.org/10.1159/000539376.

MLA (9th ed.) Citation

T, Kızılay, et al. "Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study." European Neurology, vol. 87, no. 4, 2024, p. 203, https://doi.org/10.1159/000539376.